Spain
· Delayed Price · Currency is EUR Laboratorio Reig Jofre Statistics
Total Valuation
Laboratorio Reig Jofre has a market cap or net worth of EUR 225.77 million. The enterprise value is 280.77 million.
| Market Cap | 225.77M |
| Enterprise Value | 280.77M |
Important Dates
The last earnings date was Thursday, October 31, 2024.
| Earnings Date | Oct 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Laboratorio Reig Jofre has 80.06 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 80.06M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 9.55% |
| Float | 22.03M |
Valuation Ratios
The trailing PE ratio is 23.63 and the forward PE ratio is 20.14. Laboratorio Reig Jofre's PEG ratio is 0.90.
| PE Ratio | 23.63 |
| Forward PE | 20.14 |
| PS Ratio | 0.68 |
| PB Ratio | 1.06 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.90 |
Enterprise Valuation
| EV / Earnings | 29.39 |
| EV / Sales | 0.84 |
| EV / EBITDA | 7.78 |
| EV / EBIT | 20.20 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.83, with a Debt / Equity ratio of 0.31.
| Current Ratio | 1.83 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 1.81 |
| Debt / FCF | n/a |
| Interest Coverage | 9.62 |
Financial Efficiency
Return on equity (ROE) is 4.61% and return on invested capital (ROIC) is 3.20%.
| Return on Equity (ROE) | 4.61% |
| Return on Assets (ROA) | 2.55% |
| Return on Capital (ROIC) | 3.20% |
| Revenue Per Employee | 250,707 |
| Profits Per Employee | 7,177 |
| Employee Count | 1,331 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 2.36 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.33% in the last 52 weeks. The beta is 0.92, so Laboratorio Reig Jofre's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | +19.33% |
| 50-Day Moving Average | 2.88 |
| 200-Day Moving Average | 2.74 |
| Relative Strength Index (RSI) | 41.55 |
| Average Volume (20 Days) | 14,845 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Laboratorio Reig Jofre had revenue of EUR 333.69 million and earned 9.55 million in profits. Earnings per share was 0.12.
| Revenue | 333.69M |
| Gross Profit | 189.15M |
| Operating Income | 13.98M |
| Pretax Income | 10.67M |
| Net Income | 9.55M |
| EBITDA | 32.64M |
| EBIT | 13.98M |
| Earnings Per Share (EPS) | 0.12 |
Balance Sheet
The company has 10.60 million in cash and 65.60 million in debt, giving a net cash position of -55.00 million or -0.69 per share.
| Cash & Cash Equivalents | 10.60M |
| Total Debt | 65.60M |
| Net Cash | -55.00M |
| Net Cash Per Share | -0.69 |
| Equity (Book Value) | 212.07M |
| Book Value Per Share | 2.65 |
| Working Capital | 67.02M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 56.68%, with operating and profit margins of 4.19% and 2.86%.
| Gross Margin | 56.68% |
| Operating Margin | 4.19% |
| Pretax Margin | 3.20% |
| Profit Margin | 2.86% |
| EBITDA Margin | 9.78% |
| EBIT Margin | 4.19% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 1.42%.
| Dividend Per Share | 0.04 |
| Dividend Yield | 1.42% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 1.42% |
| Earnings Yield | 4.23% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on September 22, 2015. It was a reverse split with a ratio of 0.05.
| Last Split Date | Sep 22, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |